SSc

September 1, 2015October 28, 2015

Experimental Systemic Sclerosis Therapy Resunab Enters Phase 2 Clinical Trials

News

Clinical stage drug development company Corbus Pharmaceuticals Holdings, Inc. recently announced the enrollment of patients suffering from systemic sclerosis (SSc) in Phase 2 clinical studies of an experimental therapy called Resunab designed to treat SSc as ... Read more

June 11, 2015November 6, 2015

Breakthrough Therapy Status Granted to Roche’s SSc Treatment

News, Scleroderma

Roche was recently granted breakthrough therapy designation (BTD) by the U.S. Food and Drug Administration (FDA) for its combined treatment ACTEMRA/RoACTEMRA (tocilizumab) for systemic sclerosis (SSc). The status was awarded based on successful ... Read more

June 4, 2015November 5, 2015

Model to Predict IPF Mortality Used Successfully in Systemic Sclerosis-Associated Interstitial Lung Disease

Idiopathic Pulmonary Fibrosis, News

Researchers at the University of British Columbia in Canada recently reported that mortality prediction models used in patients with idiopathic pulmonary fibrosis (IPF) can also be employed to assess short-term ... Read more